ทำไม Accelerating time-to-market through quality by design?
... allows reliable forecasts with which the quality and efficiency of the process can be continuously improved
-Design, analyze, and control pharma manufacturing processes
-Integrated PAT Data Management
-Standard analyzer connection, data collection & instrument control
-Bidirectional communication with process analyzers for 21CFR11
-Online monitoring to ensure operation within specifications.
-Offline capabilities: bidirectional interaction with multiple modeling tools
-Enable quality by design (QbD) processes.
-SIMATIC SIPAT Technology
ประโยชน์
- Time-to-market reduced by 90%.
- 33% increase in system capacity.
- Up to 20% reduction in production costs.
- Central PAT data management
- Supporting QbD-based process development in a structured way
- Real-time quality prediction & monitoring
- Enabling Real time release
- Reduce Scrap/Rework
- Reduce development & production time
- Part of Digital Twin initiatives
- GMP & FDA compliance
สำรวจแหล่งข้อมูลและผลิตภัณฑ์ที่เกี่ยวข้อง
ข้อมูลและแหล่งข้อมูลเพิ่มเติม
เงื่อนไขเบื้องต้น
None